Concizumab Plasma Concentration Measurements for Personalized Dose Adjustment in Patients with Hemophilia A/B with and without Inhibitors: Data from the Phase 3 explorer7 and explorer8 Studies

Disease Areas
Congresses
Scientific Publications
IME

Search Science Hub

Register Login

My Account

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

Congresses
ASH 2025
Concizumab Plasma Concentration Measurements for Personalized Dose Adjustment in Patients with Hemophilia A/B with and without Inhibitors: Data from the Phase 3 explorer7 and explorer8 Studies